FDA DrugsClass II

Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.

Publicado: 21 de enero de 2026ID de Retiro: D-0259-2026Categoría: Medicamentos y FármacosPaís: Estados Unidos
US
PharmaceuticalFDA DrugsUSUS

Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.

Recalling Firm: Alvogen, Inc

🌐
Traducir AvisoTranslate notice text, hazard warnings, and descriptions into any supported language.

Motivo del Retiro / Peligro

Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

Descripción del Producto e Identificación

Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.

Additional Source Details

FieldValue
CityMorristown
StateNJ
Openfda › Upc › 10347781649906
Openfda › Upc › 20347781671907
Openfda › Upc › 30347781643904
Openfda › Upc › 40347781657901
Openfda › Upc › 50347781640903
Openfda › Upc › 60347781651909
Openfda › Upc › 70347781662905
Openfda › Upc › 80347781665906
Openfda › Upc › 90347781646905
Openfda › Upc › 100347781654900
Openfda › Upc › 110347781659905
Openfda › Unii9J765S329G
Openfda › RouteORAL
Openfda › Rxcui › 1892246
Openfda › Rxcui › 2892251
Openfda › Rxcui › 3892255
Openfda › Rxcui › 4966220
Openfda › Rxcui › 5966221
Openfda › Rxcui › 6966222
Openfda › Rxcui › 7966224
Openfda › Rxcui › 8966225
Openfda › Rxcui › 9966248
Openfda › Rxcui › 10966249
Openfda › Rxcui › 11966253
Openfda › Rxcui › 12966270
Openfda › Spl id12e236b4-dc71-96ce-cdd3-7bede41b3f1c
Openfda › Brand nameLEVOTHYROXINE SODIUM
Openfda › Spl set id4ddcaec1-a58f-340b-9bc1-bbe048b8c885
Openfda › Package ndc › 147781-640-90
Openfda › Package ndc › 247781-640-10
Openfda › Package ndc › 347781-643-90
Openfda › Package ndc › 447781-643-10
Openfda › Package ndc › 547781-646-90
Openfda › Package ndc › 647781-646-10
Openfda › Package ndc › 747781-649-90
Openfda › Package ndc › 847781-649-10
Openfda › Package ndc › 947781-651-90
Openfda › Package ndc › 1047781-651-10
Openfda › Package ndc › 1147781-654-90
Openfda › Package ndc › 1247781-654-10
Openfda › Package ndc › 1347781-657-90
Openfda › Package ndc › 1447781-657-10
Openfda › Package ndc › 1547781-659-90
Openfda › Package ndc › 1647781-659-10
Openfda › Package ndc › 1747781-662-90
Openfda › Package ndc › 1847781-662-10
Openfda › Package ndc › 1947781-665-90
Openfda › Package ndc › 2047781-665-10
Openfda › Package ndc › 2147781-668-90
Openfda › Package ndc › 2247781-668-10
Openfda › Package ndc › 2347781-671-90
Openfda › Package ndc › 2447781-671-10
Openfda › Product ndc › 147781-640
Openfda › Product ndc › 247781-643
Openfda › Product ndc › 347781-646
Openfda › Product ndc › 447781-649
Openfda › Product ndc › 547781-651
Openfda › Product ndc › 647781-654
Openfda › Product ndc › 747781-657
Openfda › Product ndc › 847781-659
Openfda › Product ndc › 947781-662
Openfda › Product ndc › 1047781-665
Openfda › Product ndc › 1147781-668
Openfda › Product ndc › 1247781-671
Openfda › Generic nameLEVOTHYROXINE SODIUM
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameLEVOTHYROXINE SODIUM
Openfda › Manufacturer nameAlvogen, Inc.
Openfda › Application numberNDA021116
Openfda › Is original packagertrue
Event id98225
Address 144 Whippany Rd Ste 300
Code infoLot # MHA21825, Exp Date: December 31, 2027
Postal code07960-4558
Report date20260121
Product typeDrugs
Reason for recallProduct Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20251231
Initial firm notificationLetter
Center classification date20260114

Consumer Action Protocol: What You Should Do Immediately

Safety Steps
1Verify Product Identifiers

Inspect the NDC code, batch number, or control number on your medicine bottle or blister packaging to confirm whether your unit is included.

2Isolate & Discontinue Use

Do not abruptly stop critical prescribed medication without physician advice. Contact your dispensing pharmacist immediately for a safe alternative.

3Claim Free Statutory Remedy

Under statutory consumer protection rules, consumers are entitled to a full refund, certified replacement, or free repair kit without needing the original sales receipt.

4Report Adverse Incidents

If you suffered an injury, illness, or property damage from this product, file an official incident report with regulatory authorities (FDA Drugs).

Your Legal Rights as a Consumer

Recalls are legally binding corrective safety actions overseen by statutory government bodies. Recalling entities are legally prohibited from charging consumers for official safety remedies. If a retailer or dealership refuses your recall remedy, notify the issuing regulatory agency immediately.

Frequently Asked Questions About This Recall

FAQ Guide

Q1:What should I do immediately if I own or bought Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoa...?

Check the lot number and NDC on your prescription label. For essential medications, consult your doctor or dispensing pharmacist immediately before abruptly stopping your dose.

Q2:Can I get a full refund or free repair for this recall?

Yes. Recalling manufacturers and retail merchants are required under consumer protection regulations to offer a statutory remedy—typically a full refund, certified repair kit, or replacement unit.

Q3:Do I need my original sales receipt to claim a remedy or refund?

In most recall cases, no receipt is required. Because safety recalls are matters of public health and statutory compliance, retailers and manufacturers routinely issue refunds, store credit, or replacement kits upon presentation of the affected product or lot code.

Q4:Where can I verify official information for this safety alert?

This safety alert is aggregated directly from official regulatory agency records (FDA Drugs). You can click the 'Official Agency Alert' link on this page to view the primary government notice and contact the manufacturer directly.

Revise otros productos en su hogar

Herramientas Gratuitas

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Resumen

  • Empresa ResponsableAlvogen, Inc
  • StatusOngoing
  • Nivel de RiesgoClass II
  • DistributionUS Nationwide.
Recall Hazard Severity
High Alert (Class I)
Alerta Oficial de la Agencia

📢 Compartir advertencia

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Alvogen, Inc - Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.

Check if your household is affected:
https://therecallfile.com/es/recalls/levothyroxine-sodium-tablets-usp-thyro-tabs-150mcg-1000-tablets-rx-onl/FDA-D-0259-2026
WhatsAppFacebook

Unirse a la lista de alertas

Reciba alertas por correo electrónico cuando se publiquen retiros críticos.

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Donate with PayPal

Supports USD, EUR, GBP, International Cards & PayPal

Spread the WordLevothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.